2022 STUDY Reveals Better Health Outcomes and Significant Cost Savings
CLOSE
Enter your search term and press enter. Press Esc or X to close.

News

2022 STUDY Reveals Better Health Outcomes and Significant Cost Savings

Our mission to serve the most vulnerable with access to medication drives the ongoing commitment to measure and report on outcomes. In 2015, the Advisory Board Company produced a study and subsequent white paper that established the foundation of evidence of improved health outcomes and health system savings. We were not surprised but certainly pleased to see $650,000 in attributable savings per 1,000 patients. WATCH THE VIDEO. The 2015 study included one health system in a single geographic area. A broader research pursuit was necessary to realize the expansive pragmatic benefits of partnering with Dispensary of Hope.

Today, we are releasing a national study with RTI International, which shows reduced hospital utilization for patients enrolled in a Dispensary of Hope medication access program, delivering health system savings of $3.1 MILLION per thousand patients per year and decreases in inpatient stays by 20%. The study also shows promise for Dispensary of Hope as a powerful HEALTH EQUITY resource–more than half of the patients identified as Black/African American.

CLICK TO DOWNLOAD THE IMPACTS AND SAVINGS ONE PAGER OR CLICK TO DOWNLOAD THE FULL REPORT
Share |